AVACTA LIFE SCIENCES LTD has a total of 30 patent applications. It increased the IP activity by 900.0%. Its first patent ever was published in 2009. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and pharmaceuticals are BIOMUNEX PHARMACEUTICALS, SHANGHAI EPIMAB BIOTHERAPEUTICS CO LTD and WEREWOLF THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Singapore | 2 | |
#10 | Taiwan | 2 | |
#11 | United States | 2 | |
#12 | Hungary | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Adam Estelle | 10 |
#2 | Jenkins Emma | 10 |
#3 | Basran Amrik | 10 |
#4 | Stanley Emma | 9 |
#5 | Platt Geoff William | 9 |
#6 | Writer Michelle | 8 |
#7 | Spence Graham Robert Pye-Smith | 8 |
#8 | Gendra Elisenda | 3 |
#9 | Ko Ferrigno Paul | 3 |
#10 | Vincent Matthew | 2 |
Publication | Filing date | Title |
---|---|---|
GB202101299D0 | Diagnostic polypetides and methods | |
WO2021074683A1 | Bispecific anti-pd-l1 and anti-fcrn polypeptides | |
WO2021074695A1 | PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES. | |
GB202014725D0 | Diagnostic polypeptides and methods | |
GB202008694D0 | Pathogen binding polypeptides, and uses related thereto | |
GB201805963D0 | PD-L1 Binding Affirmers and Uses Related Thereto | |
GB201710973D0 | Scaffold proteins |